Loading clinical trials...

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01346969

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

The study will investigate the efficacy of various doses and regimens of EXC 001 in reducing skin scarring in subjects undergoing revision of scars from prior surgery. The study will also evaluate the...

Lead sponsor: Pfizer•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment68

Start dateJun 2011

Last updatedSep 9, 2021

Condition

Reduction in Hypertrophic Skin Scarring

Locations shown

Skin Deep Laser Medical Spa

Pasadena, California

Bright Health Physicans Plastic Surgery and Aesthetic Medicine

Whittier, California

Altus Research

Lake Worth, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions